Haematological malignancies Flashcards
characteristics of acute haematological malignancies?
rapidly progressive, fatal within days-wks if not treated
immature (blast) cells predominate
how is distinction between myeloid or lymphoid classification of malignancy made?
analysis of proteins on cell surface (surface antigens)-immunophenotyping- can be done via flow cytometry.
population mainly affected by acute lymphoblastic leukaemia (ALL)?
children
population mainly affected by chronic lymphocytic leukaemia (CLL)?
elderly
RFs for leukaemia?
radiation
chemical and drugs e.g. benzene in industry, alkylating agents-AML, e.g. cytotoxic chemotherapy with cyclophosphamide, and topoisomerase II inhibitors
genetic e.g. Fanconi syndrome, ataxia telangiectasia, increased risk with trisomy 21. genes e.g. RUNX1 and CEBPA associations.
viruses e.g. human T cell lymphotropic retrovirus type 1 (HTLV-1)
which chromosomal abnormality is assoc. with 97% of chronic myeloid leukaemia cases?
philadelphia chromosome-an abnormal chromosome 22, reciprocal translocation between part of long arm of 22 and 9. so t (9;22) karyotype.
also found in ALL
results in formation of a fusion gene-translation produces fusion protein with TK activity and enhanced phosphorylating activity, causing altered cell growth, stromal attachment and reduced apoptosis.
commonest malignancy in childhood?
acute lymphoblastic leukaemia
symptoms suggestive of marrow failure in acute leukaemia?
breathlessness
fatigue
angina
claudication-anaemia
infections-neutropenia, common infections in ALL- CMV, zoster, meningitis, candidiasis, pneumocystis pneumonia.
bleeding and bruising-thrombocytopenia-petechiae, gum bleeding, fundal haemorrhage
symptoms suggestive of high WBC in acute leukaemia?
breathlessness
headache
confusion
visual problems
all result of leuostasis
symptoms suggestive of tissue infiltration in acute leukaemia?
bone pain
headache, cranial nerve palsies, meningism
symptoms suggestive of substance release from tumour cells in acute leukaemia?
bleeding and bruising-DIC
acute gout-hyperuricaemia
confirmation of acute leuakemia with blood count?
Hb low-anaemia
WBC usually raised
PLT low
confirmation of acute leukaemia with blood film?
blast cells
may be morphological identification of lineage e.g. Auer rods in blast cells in AML.
investigations for acute leukaemia diagnosis?
blood count
coagulation profile- to exclude DIC- low PLT (although can be raised in malignancy-chronic DIC), raised PT, APTT, reduced fibrinogen, increased fibrin degradation products e.g. D-dimers.
blood film
BM aspirate- increased cellularity, reduced erythropoieis and megakaryocytes (PLT precursor), replacement by blast cells, lineage confirmed with immunophenotyping.
CXR-mediastinal widening in T lymphoblastic leukaemia
CSF exam.-risk of CNS involvement in ALL HIGH.
therapy planning: US and Es, LFTs, serum urate
cardiac function-ECG and direct LV function tests e.g. echo.
principles of specific acute leukaemia tment?
induction chemotherapy
consolidation
additional tment to that used in AML for ALL?
need for CNS directed therapy- intrathecal chemotherapy
after intensive induction and consolidation, need 2 yr maintenance therapy to reduce risk of recurrence- MTX and mercaptopurine.
how can WCC be lowered in acute leukaemia to reduce leukostasis adverse consequences e.g. WBC thrombi in brain, heart and lungs?
hydroxycarbamide
leukopheresis
characteristic sign of Burkitt’s lymphoma?
jaw lymphadenopathy
characteristic cells with mirror-image nuclei found in Hodkin’s lymphoma?
Reed-Sternberg cells
staging of Hodkin’s lymphoma?
Ann-Arbor staging: 1-LN 2-LNs on same side of diaphragm 3-LNs on both sides of diaphragm 4-extra-lymph nodal involvement
what can be given as supportive therapy to prevent tumour lysis syndrome in ALL?
allopurinol- inhibitor of xanthine oxidase
when is matched related allogeneic marrow transplantation considered in ALL patients?
once in 1st remission is best option in standard-risk younger adults